MedTrace Logo

Chronic Heart Failure - Cheyne Stokes Respiration - CS2 (3C-study)

NCT00563693 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2015-12-03

No results posted yet for this study

Summary

An investigation where patients with chronic heart failure and cheyne stokes respiration, treated with adapitve servo ventilator, will improve their cardiac function and quality of life.

Conditions

Interventions

DEVICE

ASV

Adaptive servo ventilator

OTHER

without Autoset CS2

without Autoset CS2

Sponsors & Collaborators

  • ResMed

    collaborator INDUSTRY

  • University of Oslo

    lead OTHER

Principal Investigators

  • Arild Hetland, cardiologist · University of Oslo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2011-01-31
Completion
2011-01-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00563693 on ClinicalTrials.gov